[18F]ODIBO: a prosthetic group for bioorthogonal radiolabeling of macromolecules via strain-promoted alkyne–azide cycloaddition

Literature Information

Publication Date 2017-11-15
DOI 10.1039/C7OB02532G
Impact Factor 3.876
Authors

Mehdi Boudjemeline, Christopher D. McNitt, Thomas A. Singleton, Vladimir V. Popik, Alexey P. Kostikov


View Original

Abstract

A novel prosthetic group for the efficient radiolabeling of macromolecules has been developed. [18F]oxadibenzocyclooctyne ([18F]ODIBO) is synthesized in high radiochemical yield and applied for nearly quantitative conjugation to azide-tagged peptides and proteins at room temperature and low substrate concentrations. The resulting bioconjugates are chemically and radiochemically pure and free of toxic solvents and catalysts.

Related Literature

Recyclable and efficient polyurethane-Ir catalysts for direct borylation of aromatic compounds

Akihiro Kimura, Haruka Hayama, Hassan Nageh, Yue Wang, Naofumi Naga

2017-11-09 Paper

DOI: 10.1039/C7PY01509G

Synthesis of enzyme-responsive phosphoramidate dendrimers for cancer drug delivery

Zhen Zhang, Yongcun Zhou, Zhuxian Zhou, Ying Piao, Nagendra Kalva, Xiangrui Liu, Jianbin Tang, Youqing Shen

2017-12-18 Paper

DOI: 10.1039/C7PY01492A

Ferromagnetic iron oxide–cellulose nanocomposites prepared by ultrasonication

Razvan Rotaru, Marcela Savin, Nita Tudorachi, Cristian Peptu, Petrisor Samoila, Liviu Sacarescu, Valeria Harabagiu

2017-10-27 Paper

DOI: 10.1039/C7PY01587A

Main-chain benzoxazine precursor block copolymers

Zeynep Deliballi, Baris Kiskan, Yusuf Yagci

2017-11-28 Paper

DOI: 10.1039/C7PY01873H

Front cover

Cover

DOI: 10.1039/C7PY90185B

Significantly improved energy density of BaTiO3 nanocomposites by accurate interfacial tailoring using a novel rigid-fluoro-polymer

Sheng Chen, Xuguang Lv, Xianghui Han, Hang Luo, Chris R. Bowen, Dou Zhang

2017-12-08 Paper

DOI: 10.1039/C7PY01914A

Front cover

Cover

DOI: 10.1039/C8PY90120A

Back cover

Cover

DOI: 10.1039/C8PY90126K

Thermoresponsive hybrid double-crosslinked networks using magnetic iron oxide nanoparticles as crossing points

Thomas Blin, Antoine Niederberger, Lazhar Benyahia, Jérôme Fresnais, Véronique Montembault, Laurent Fontaine

2018-08-14 Paper

DOI: 10.1039/C8PY01006D

Synthesis of poly(ionic liquid)-based nano-objects with morphological transitions via RAFT polymerization-induced self-assembly in ethanol

Yongqi Yang, Jinwen Zheng, Shoukuo Man, Xiaolan Sun, Zesheng An

2018-01-23 Communication

DOI: 10.1039/C8PY00040A

You might also like

Compound Q&A

What are the main uses of (3.beta.)-3-Hydroxy-N,N-dimethyl-chol-5-en-24-amide (CAS: 79066-03-8)?

(3.beta.)-3-Hydroxy-N,N-dimethyl-chol-5-en-24-amide (CAS: 79066-03-8) is primari...

79066-03-8(3.beta.)-3-Hydroxy-...
Compound Q&A

What regulatory guidelines apply to 5-(aminomethyl)-2-methoxyphenol (CAS: 89702-89-6)?

5-(Aminomethyl)-2-methoxyphenol (CAS: 89702-89-6) is classified under GHS as a s...

89702-89-65-(aminomethyl)-2-me...
Compound Q&A

What is Thieno[2,3-c]pyridin-7(6H)-one (CAS: 28981-13-7)?

Thieno[2,3-c]pyridin-7(6H)-one (CAS: 28981-13-7) is a heterocyclic organic compo...

28981-13-7Thieno[2,3-c]pyridin...
Compound Q&A

Is 1-[(6-Methoxy-3-pyridinyl)methyl]-4-piperidinamine dihydrochloride (CAS: 1185311-28-7) safe?

1-[(6-Methoxy-3-pyridinyl)methyl]-4-piperidinamine dihydrochloride is generally ...

1185311-28-71-[(6-Methoxy-3-pyri...
Compound Q&A

What regulatory guidelines apply to [(2E)-3-Phenyl-2-propen-1-yl]phosphonic acid (CAS: 146404-58-2)?

[(2E)-3-Phenyl-2-propen-1-yl]phosphonic acid (CAS: 146404-58-2) is regulated und...

146404-58-2[(2E)-3-Phenyl-2-pro...
Compound Q&A

What regulatory guidelines apply to 6-Bromo-7-methoxyquinoline (CAS: 1620515-86-7)?

6-Bromo-7-methoxyquinoline (CAS: 1620515-86-7) falls under the scope of the Glob...

1620515-86-76-Bromo-7-methoxyqui...
Compound Q&A

What industries use (2R)-1-(1-Benzofuran-2-yl)-N-propyl-2-pentanamine (CAS: 260550-89-8)?

This compound is primarily used in the pharmaceutical industry for the developme...

260550-89-8(2R)-1-(1-Benzofuran...
1228013-15-71-Ethyl-7-[2-methyl-...
Compound Q&A

Are there alternatives to {5-(Acryloylamino)-2-[(dimethylamino)methyl]phenyl}boronic acid (CAS: 1217500-78-1) in synthesis?

Alternative reagents such as 2-[(dimethylamino)methyl]phenylboronic acid or rela...

1217500-78-1{5-(Acryloylamino)-2...
Compound Q&A

What is 3-(Piperidin-4-yloxy)pyridine (CAS: 310881-48-2)?

3-(Piperidin-4-yloxy)pyridine (CAS: 310881-48-2) is an organic compound with the...

310881-48-23-(Piperidin-4-yloxy...

Source Journal

Organic & Biomolecular Chemistry

Organic & Biomolecular Chemistry
CiteScore: 3.4
Self-citation Rate: 10.3%
Articles per Year: 1041

Organic & Biomolecular Chemistry (OBC) publishes original and high impact research and reviews in organic chemistry. We welcome research that shows new or significantly improved protocols or methodologies in total synthesis, synthetic methodology or physical and theoretical organic chemistry as well as research that shows a significant advance in the organic chemistry or molecular design aspects of chemical biology, catalysis, supramolecular and macromolecular chemistry, theoretical chemistry, mechanism-oriented physical organic chemistry, medicinal chemistry or natural products. Articles published in the journal should report new work which makes a highly-significant impact in the field. Routine and incremental work is generally not suitable for publication in the journal. More details about key areas of our scope are below. In all cases authors should include in their article clear rationale for why their research has been carried out.

Recommended Compounds

Recommended Suppliers

Disclaimer
This page provides academic journal information for reference and research purposes only. We are not affiliated with any journal publishers and do not handle publication submissions. For publication-related inquiries, please contact the respective journal publishers directly.
If you notice any inaccuracies in the information displayed, please contact us at support@chemtradehub.com. We will promptly review and address your concerns.